Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Anti-glycoprotein Ibα autoantibodies do not impair circulating thrombopoietin levels in immune thrombocytopenia patients.

Porcelijn L, Schmidt DE, van der Schoot CE, Vidarsson G, de Haas M, Kapur R.

Haematologica. 2019 Jul 11. pii: haematol.2019.228908. doi: 10.3324/haematol.2019.228908. [Epub ahead of print]

2.

Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms.

Schmidt DE, Heitink-Pollé KMJ, Laarhoven AG, Bruin MCA, Veldhuisen B, Nagelkerke SQ, Kuijpers TW, Porcelijn L, van der Schoot CE, Vidarsson G, de Haas M.

Blood Adv. 2019 Jul 9;3(13):2003-2012. doi: 10.1182/bloodadvances.2019000068.

3.

Correlation of thromboelastography and thrombin generation assays in warfarin-treated patients.

Schmidt DE, Chaireti R, Bruzelius M, Holmström M, Antovic J, Ågren A.

Thromb Res. 2019 Jun;178:34-40. doi: 10.1016/j.thromres.2019.03.022. Epub 2019 Apr 1.

PMID:
30959280
4.

Whole blood ristocetin-activated platelet impedance aggregometry (Multiplate) for the rapid detection of Von Willebrand disease.

Schmidt DE, Bruzelius M, Majeed A, Odeberg J, Holmström M, Ågren A.

Thromb Haemost. 2017 Jul 26;117(8):1528-1533. doi: 10.1160/TH17-02-0129. Epub 2017 Jul 6.

PMID:
28692107
5.

Relative effects of plasma, fibrinogen concentrate, and factor XIII on ROTEM coagulation profiles in an in vitro model of massive transfusion in trauma.

Schmidt DE, Halmin M, Wikman A, Östlund A, Ågren A.

Scand J Clin Lab Invest. 2017 Oct;77(6):397-405. doi: 10.1080/00365513.2017.1334128. Epub 2017 Jun 20.

PMID:
28632435
6.

A prospective diagnostic accuracy study evaluating rotational thromboelastometry and thromboelastography in 100 patients with von Willebrand disease.

Schmidt DE, Majeed A, Bruzelius M, Odeberg J, Holmström M, Ågren A.

Haemophilia. 2017 Mar;23(2):309-318. doi: 10.1111/hae.13121. Epub 2016 Oct 26.

PMID:
27785858
7.

Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.

Ågren A, Holmström M, Schmidt DE, Hosokawa K, Blombäck M, Hjemdahl P.

Thromb Haemost. 2017 Jan 5;117(1):75-85. doi: 10.1160/TH16-06-0430. Epub 2016 Oct 20.

PMID:
27761577
8.

CC chemokine ligands in patients presenting with stable chest pain: association with atherosclerosis and future cardiovascular events.

Versteylen MO, Manca M, Joosen IA, Schmidt DE, Das M, Hofstra L, Crijns HJ, Biessen EA, Kietselaer BL.

Neth Heart J. 2016 Dec;24(12):722-729.

9.

Determination of equilibrium constant of amino carbamate adduct formation in sisomicin by a high pH based high performance liquid chromatography.

Wlasichuk KB, Tan L, Guo Y, Hildebrandt DJ, Zhang H, Karr DE, Schmidt DE Jr.

J Pharm Biomed Anal. 2015;111:126-30. doi: 10.1016/j.jpba.2015.03.033. Epub 2015 Apr 3.

PMID:
25880243
10.

Circulating endothelial cells in coronary artery disease and acute coronary syndrome.

Schmidt DE, Manca M, Hoefer IE.

Trends Cardiovasc Med. 2015 Oct;25(7):578-87. doi: 10.1016/j.tcm.2015.01.013. Epub 2015 Feb 7. Review.

PMID:
25753180
11.

Detection of elevated INR by thromboelastometry and thromboelastography in warfarin treated patients and healthy controls.

Schmidt DE, Holmström M, Majeed A, Näslin D, Wallén H, Ågren A.

Thromb Res. 2015 May;135(5):1007-11. doi: 10.1016/j.thromres.2015.02.022. Epub 2015 Feb 26.

PMID:
25746367
12.

Thrombin generation in a patient with an acquired high-titre factor V inhibitor.

Schmidt DE, Steinhagen F, Schnabel C, Spath B, Holstein K, Fiedler W, Bokemeyer C, Renné T, Langer F.

Blood Coagul Fibrinolysis. 2015 Jan;26(1):81-7. doi: 10.1097/MBC.0000000000000181.

PMID:
25158984
13.

Output control of da Vinci surgical system's surgical graspers.

Johnson PJ, Schmidt DE, Duvvuri U.

J Surg Res. 2014 Jan;186(1):56-62. doi: 10.1016/j.jss.2013.07.032. Epub 2013 Aug 8.

PMID:
23968806
14.

The evaluation of 25 chiral stationary phases and the utilization of sub-2.0μm coated polysaccharide chiral stationary phases via supercritical fluid chromatography.

Hamman C, Wong M, Aliagas I, Ortwine DF, Pease J, Schmidt DE Jr, Victorino J.

J Chromatogr A. 2013 Aug 30;1305:310-9. doi: 10.1016/j.chroma.2013.07.046. Epub 2013 Jul 17.

PMID:
23891213
15.

Oscillatory shear stress created by fluid pulsatility versus flexed specimen configurations.

Salinas M, Schmidt DE, Libera M, Lange RR, Ramaswamy S.

Comput Methods Biomech Biomed Engin. 2014 May;17(7):728-39. doi: 10.1080/10255842.2012.715157. Epub 2012 Aug 24. Erratum in: Comput Methods Biomech Biomed Engin. 2014;17(8):932.

PMID:
22920330
16.

A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.

Tan L, Wlasichuk KB, Schmidt DE Jr, Campbell RL, Hirtzer P, Cheng L, Karr DE.

J Pharm Biomed Anal. 2012 Jul;66:75-84. doi: 10.1016/j.jpba.2012.03.003. Epub 2012 Mar 10.

PMID:
22459505
17.

The use of ammonium hydroxide as an additive in supercritical fluid chromatography for achiral and chiral separations and purifications of small, basic medicinal molecules.

Hamman C, Schmidt DE Jr, Wong M, Hayes M.

J Chromatogr A. 2011 Oct 28;1218(43):7886-94. doi: 10.1016/j.chroma.2011.08.064. Epub 2011 Sep 3.

PMID:
21939976
18.

The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells.

Ramaswamy S, Gottlieb D, Engelmayr GC Jr, Aikawa E, Schmidt DE, Gaitan-Leon DM, Sales VL, Mayer JE Jr, Sacks MS.

Biomaterials. 2010 Feb;31(6):1114-25. doi: 10.1016/j.biomaterials.2009.10.019. Epub 2009 Nov 26.

19.

On the mechanical role of de novo synthesized elastin in the urinary bladder wall.

Wognum S, Schmidt DE, Sacks MS.

J Biomech Eng. 2009 Oct;131(10):101018. doi: 10.1115/1.4000182.

PMID:
19831488
20.

On the biomechanics of heart valve function.

Sacks MS, David Merryman W, Schmidt DE.

J Biomech. 2009 Aug 25;42(12):1804-24. doi: 10.1016/j.jbiomech.2009.05.015. Epub 2009 Jun 21. Review.

21.

The effects of anisotropy on the stress analyses of patient-specific abdominal aortic aneurysms.

Vande Geest JP, Schmidt DE, Sacks MS, Vorp DA.

Ann Biomed Eng. 2008 Jun;36(6):921-32. doi: 10.1007/s10439-008-9490-3. Epub 2008 Apr 9.

22.

Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons.

Neely MD, Schmidt DE, Deutch AY.

Neuroscience. 2007 Oct 26;149(2):457-64. Epub 2007 Jul 17.

23.

MyChart-A New Mode of Care Delivery: 2005 Personal Health Link Research Report.

Serrato CA, Retecki S, Schmidt DE.

Perm J. 2007 Spring;11(2):14-20. No abstract available.

24.

Central neurochemical ultradian variability in depression.

Salomon RM, Johnson BW, Schmidt DE.

Dis Markers. 2006;22(1-2):65-72.

25.

Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes.

Salomon RM, Kennedy JS, Johnson BW, Urbano Blackford J, Schmidt DE, Kwentus J, Gwirtsman HE, Gouda JF, Shiavi RG.

Neuropsychopharmacology. 2005 Nov;30(11):2082-91.

26.

Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus.

Higgins DL, Chang R, Debabov DV, Leung J, Wu T, Krause KM, Sandvik E, Hubbard JM, Kaniga K, Schmidt DE Jr, Gao Q, Cass RT, Karr DE, Benton BM, Humphrey PP.

Antimicrob Agents Chemother. 2005 Mar;49(3):1127-34.

27.

Increasing the efficiency of pharmacokinetic sample procurement, preparation and analysis by liquid chromatography/tandem mass spectrometry.

Villa JS, Cass RT, Karr DE, Adams SM, Shaw JP, Schmidt DE Jr.

Rapid Commun Mass Spectrom. 2004;18(10):1066-72.

PMID:
15150829
28.

Association of a critical CSF tryptophan threshold level with depressive relapse.

Salomon RM, Kennedy JS, Johnson BW, Schmidt DE, Kwentus J, Gwirtsman HE, Ebert MH.

Neuropsychopharmacology. 2003 May;28(5):956-60. Epub 2003 Mar 19.

29.

Low or absent unconjugated estriol in pregnancy: an indicator for steroid sulfatase deficiency detectable by fluorescence in situ hybridization and biochemical analysis.

Kashork CD, Sutton VR, Fonda Allen JS, Schmidt DE, Likhite ML, Potocki L, O'Brien WE, Shaffer LG.

Prenat Diagn. 2002 Nov;22(11):1028-32.

PMID:
12424769
30.

Serial cerebrospinal fluid tryptophan and 5-hydroxy indoleacetic acid concentrations in healthy human subjects.

Kennedy JS, Gwirtsman HE, Schmidt DE, Johnson BW, Fielstein E, Salomon RM, Shiavi RG, Ebert MH, Parris WC, Loosen PT.

Life Sci. 2002 Aug 23;71(14):1703-15.

PMID:
12137916
31.

Dicinnamoylquinides in roasted coffee inhibit the human adenosine transporter.

de Paulis T, Schmidt DE, Bruchey AK, Kirby MT, McDonald MP, Commers P, Lovinger DM, Martin PR.

Eur J Pharmacol. 2002 May 10;442(3):215-23.

PMID:
12065074
32.

Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.

Zhang ZJ, Trivedi BL, de Paulis T, Schmidt DE, Hewlett WA.

Naunyn Schmiedebergs Arch Pharmacol. 2002 Feb;365(2):123-32. Epub 2001 Dec 19.

PMID:
11819030
33.

Endogenous morphine and codeine. Possible role as endogenous anticonvulsants.

Spector S, Munjal I, Schmidt DE.

Brain Res. 2001 Oct 12;915(2):155-60.

PMID:
11595204
34.

Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze.

Zhang ZJ, Schmidt DE, de Paulis T, Trivedi BL, Onaivi ES, Ebert MH, Hewlett WA.

Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):571-8.

PMID:
11509218
36.

Plasma cholecystokinin levels in Prader-Willi syndrome and obese subjects.

Butler MG, Carlson MG, Schmidt DE, Feurer ID, Thompson T.

Am J Med Genet. 2000 Nov 6;95(1):67-70.

PMID:
11074497
37.

Evaluation of plasma time-activity curves of technetium-99m-mebrofenin for measurement of hepatic function in dogs.

Matwichuk CL, Daniel GB, DeNovo RC, Schultze AE, Schmidt DE, Creevy KE.

Vet Radiol Ultrasound. 2000 Jan-Feb;41(1):78-84.

PMID:
10695885
38.
39.

Salt-induced immobilization of affinity ligands onto epoxide-activated supports.

Wheatley JB, Schmidt DE Jr.

J Chromatogr A. 1999 Jul 16;849(1):1-12. Review.

PMID:
10444838
40.

Biogenic amine activity in response to fluoxetine and desipramine in differentially reared rhesus monkeys.

Clarke AS, Ebert MH, Schmidt DE, McKinney WT, Kraemer GW.

Biol Psychiatry. 1999 Jul 15;46(2):221-8.

PMID:
10418697
41.

Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.

Hewlett WA, Trivedi BL, Zhang ZJ, de Paulis T, Schmidt DE, Lovinger DM, Ansari MS, Ebert MH.

J Pharmacol Exp Ther. 1999 Jan;288(1):221-31.

PMID:
9862774
42.

Protein affinity map of chemical space.

Kauvar LM, Villar HO, Sportsman JR, Higgins DL, Schmidt DE Jr.

J Chromatogr B Biomed Sci Appl. 1998 Sep 11;715(1):93-102.

PMID:
9792501
44.

Immunophenotypic study of acute lymphoblastic leukemia (a prospective study in Brazilian children)

de Souza MH, Diamond HR, Santos MP, Silva ML, de Azevedo AM, Wajnberg H, da Silva TM, Schmidt Lde H, Deterling LC, Campos MM, Harab RC, Básica P.

Med Pediatr Oncol. 1998 Sep;31(3):185-6. No abstract available.

PMID:
9722906
45.

Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine.

Nalepa I, Manier DH, Gillespie DD, Rossby SP, Schmidt DE, Sulser F.

Eur Neuropsychopharmacol. 1998 Aug;8(3):227-32.

PMID:
9716317
46.

Otolaryngological manifestations of Creutzfeldt-Jakob disease.

Bigelow DC, Eisen MD, Yen DM, Saull SC, Solomon D, Schmidt DE.

Arch Otolaryngol Head Neck Surg. 1998 Jun;124(6):707-10.

PMID:
9639484
47.
48.

Characterization of desamino-5-[125I]iodo-3-methoxy-zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain.

Hewlett WA, Fridman S, Trivedi BL, Schmidt DE, de Paulis T, Ebert MH.

Prog Neuropsychopharmacol Biol Psychiatry. 1998 Feb;22(2):397-410.

PMID:
9608609
49.

Synthesis and 5-HT-3 receptor binding of 2- and 3-(halo)alkoxyl substituted (S)-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chlorobenzamides as potential radioligands.

Hewlett WA, Schmidt DE, Mason NS, Trivedi BL, Ebert MH, de Paulis T.

Nucl Med Biol. 1998 Feb;25(2):141-53.

PMID:
9468029
50.

Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinity.

Hewlett WA, de Paulis T, Mason NS, Schmidt DE, Trivedi BL, Zhang ZJ, Ebert MH.

Chem Pharm Bull (Tokyo). 1997 Dec;45(12):2079-84.

PMID:
9433779

Supplemental Content

Loading ...
Support Center